ired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Amarin hired Dr. Craig Granowitz as chief medical officer. Previously, he was senior vice president and head of global medical affairs in global human health at Merck, and before that, he was group vice president, head of global medical affairs for Schering-Plough.
Affimed hired Dr. Joerg Windisch as chief operating officer;
Seres Therapeutics hired Wael Hashad as chief commercial officer and executive vice president;
Avanir Pharmaceuticals named Rohan Palekar as chief executive officer and president;
Syndax Pharmaceuticals hired Allan Shaw as chief financial officer and treasurer;
StemCells named Ian Massey as chief executive officer;
ImaginAb hired Benjamin Chen as chief executive officer;
Patheon hired Gilles Cottier as president of its pharma development services division;
Enteris BioPharma hired Joel Tune as chief executive officer;
Enteris BioPharma promoted Paul Shields to chief operating officer;
Merck KGaA hired Jessie English as the vice president of discovery, translational innovation platform immuno-oncology;
Pharmaceutical Research and Manufacturers of America hired Rodger Currie as executive vice president for advocacy.